Lassen N A
Med Prog Technol. 1976 Apr 30;3(4):149-60.
A survey of the currently available methods for the measurement of cerebral blood flow in man is given. Many of the clinically important brain diseases such as tumors, stroke, brain trauma or epilepsy entail focal or regional flow alterations. Therefore a special emphasis is placed on methods allowing measurements of regional cerebral flow, rCBF. The intra-arterial 133Xenon injection method is now widely used as a standard method for rCBF measurement. It affords a good two-dimensional resolution when using a suitable dynamic gamma camera which allows a high counting rate to be recorded. But, due to the superposition of tissues the three-dimensional resolution is limited. This, in particular, means that smaller areas of ischemia (low flow) tend to be overlooked whereas local hyperemia is readily discerned. The 133Xenon inhalation method is less accurate, contaminated by extra-cerebral uptake, and insensitive both for detecting regional ischemia and regional hyperemia. The spatial resolution is also much more limited. For these reasons great caution must be exercised in interpreting the results. Methods yielding three-dimensional rCBF data will be needed in order to gain more precise information both on spatial localization and, especially, on ischemic areas. The most promising is computer-assisted axial tomography with freely diffusible radioactive isotopes or with x-rays using an intra-arterial injection of contrast. But, the available techniques are still too slow: in order to measure blood flow one "exposure" must be taken every second. Only a few methods give quantitative information of the blood flow in the human brain. This is mainly due to the inaccessibility of the brain within the skull and to the complexity of the cerebral arterial and venous systems. Before reviewing the various methods used in man, it should be mentioned, that much of the fundamental knowledge has been gained by methods only applicable to animals. Measurements of the diameter of the small arteries on the surface of the brain antedates even the classical studies of Roy and Sherrington (1890). This technique continues to be useful, modern technical improvements consisting of the use of micropipettes and a stereo microscope in combination with an image splitter and a television camera which allows the accurate assessment of diameter variations of a few percent [22]. Autoradiography of brain slices using diffusible indicators is the best quantitative method for measuring local blood flow in a great many parts of the brain [7, 45]. Microspheres are also being used, but it is still not quite clear that this technique gives reliable quantitative data in small masses of tissue [34, 41, 50].
本文对目前可用于测量人体脑血流量的方法进行了综述。许多临床上重要的脑部疾病,如肿瘤、中风、脑外伤或癫痫,都会导致局部或区域血流改变。因此,本文特别强调了能够测量局部脑血流量(rCBF)的方法。动脉内注入133氙的方法目前被广泛用作rCBF测量的标准方法。当使用合适的动态γ相机时,它能提供良好的二维分辨率,该相机可记录高计数率。但是,由于组织的叠加,三维分辨率受到限制。这尤其意味着较小的缺血区域(低血流)往往会被忽视,而局部充血则很容易被识别。吸入133氙的方法准确性较低,会受到脑外摄取的污染,并且对检测局部缺血和局部充血都不敏感。其空间分辨率也更有限。出于这些原因,在解释结果时必须格外谨慎。为了在空间定位尤其是缺血区域方面获得更精确的信息,将需要能够产生三维rCBF数据的方法。最有前景的是使用可自由扩散的放射性同位素或通过动脉内注射造影剂进行X射线扫描的计算机辅助轴向断层扫描。但是,现有的技术仍然太慢:为了测量血流量,每秒必须进行一次“曝光”。只有少数方法能提供人脑血流量的定量信息。这主要是由于颅骨内的大脑难以接近以及脑动脉和静脉系统的复杂性。在回顾用于人体的各种方法之前,应该提到的是,许多基础知识是通过仅适用于动物的方法获得的。对脑表面小动脉直径的测量甚至早于Roy和Sherrington(1890年)的经典研究。这项技术仍然很有用,现代技术改进包括使用微量移液器和立体显微镜,并结合图像分割器和电视摄像机,这使得能够准确评估百分之几的直径变化[22]。使用可扩散指示剂对脑切片进行放射自显影是测量大脑许多部位局部血流量的最佳定量方法[7,45]。微球也在被使用,但这种技术在小组织块中能否给出可靠的定量数据仍不太清楚[34,41,50]。